These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28397878)

  • 21. Clinical usefulness of anti-M-type phospholipase-A-receptor antibodies in patients with membranous nephropathy and the comparison of three quantification methods.
    Katsumata Y; Okamoto Y; Moriyama T; Moriyama R; Kawamoto M; Hanaoka M; Uchida K; Nitta K; Harigai M
    Immunol Med; 2020 Mar; 43(1):47-56. PubMed ID: 31910103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative detection and prognostic value of antibodies against M-type phospholipase A2 receptor and its cysteine-rich ricin domain and C-type lectin domains 1 and 6-7-8 in patients with idiopathic membranous nephropathy.
    Liu X; Xue J; Li T; Wu Q; Sheng H; Yang X; Lin B; Zhou X; Qin Y; Huang Z; Zhou L; Wang L; Hu Z; Huang B
    PLoS One; 2024; 19(2):e0298269. PubMed ID: 38386672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy.
    Svobodova B; Honsova E; Ronco P; Tesar V; Debiec H
    Nephrol Dial Transplant; 2013 Jul; 28(7):1839-44. PubMed ID: 23223223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Receptor antibody time-resolved A2 phospholipase bead immunochromatography and its application in idiopathic membranous nephropathy.
    Huang B; Yang X; Zhang W; Wu J; Liu P; Hu Z; Wang T
    J Clin Lab Anal; 2020 Dec; 34(12):e23508. PubMed ID: 32767448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative detection of anti-PLA2R antibodies targeting different epitopes and its clinical application in primary membranous nephropathy.
    Qin Y; Wu Q; Sheng H; Li T; Liu X; Yang X; Lin B; Zhou X; Jin J; Wang L; Huang B; He Q; Hu Z
    Clin Chem Lab Med; 2023 Jan; 61(2):251-259. PubMed ID: 36351699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PLA2R and membranous nephropathy: A 3 year prospective Australian study.
    Hill PA; McRae JL; Dwyer KM
    Nephrology (Carlton); 2016 May; 21(5):397-403. PubMed ID: 26369693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment of Galectin-3 Time-resolved Fluoroimmunoassay and its Application in Idiopathic Membranous Nephropathy.
    Yu X; Chen L; Lin B; Zhang L; Yang X; Liu X; Xia P; Liu Y; Zheng S; Zhou X; Wang Y; Qin Y; Wang L; Hu Z; He Q; Huang B
    J Fluoresc; 2022 Mar; 32(2):629-636. PubMed ID: 35025017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The characters of antibodies against PLA2R in healthy individuals and in the patient with PLA2R associated membranous nephropathy.
    Cheng YJ; Wang M; Wang J; Cui Z; Zhao MH
    Eur J Med Res; 2023 Mar; 28(1):128. PubMed ID: 36935517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy.
    Kumar V; Ramachandran R; Kumar A; Nada R; Suri D; Gupta A; Kohli HS; Gupta KL; Jha V
    Nephrology (Carlton); 2015 Aug; 20(8):572-5. PubMed ID: 26194981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.
    Hoxha E; Kneißler U; Stege G; Zahner G; Thiele I; Panzer U; Harendza S; Helmchen UM; Stahl RA
    Kidney Int; 2012 Oct; 82(7):797-804. PubMed ID: 22673885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-Phospholipase A2 Receptor Antibody as Prognostic Indicator in Idiopathic Membranous Nephropathy.
    Kim YG; Choi YW; Kim SY; Moon JY; Ihm CG; Lee TW; Jeong KH; Yang SH; Kim YS; Oh YJ; Lee SH
    Am J Nephrol; 2015; 42(3):250-7. PubMed ID: 26484659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anti-phospholipase A2 receptor (anti-PLA2R) antibodies and idiopathic membranous nephropathy: which role in diagnosis and prognosis of this disease?].
    Netti GS; Ranieri E
    G Ital Nefrol; 2014; 31(3):. PubMed ID: 25030016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new fluorescence sensor developed with polydopamine nanospheres for the detection of anti-PLA2R antibody biomarkers of idiopathic membranous nephropathy.
    Li L; Lu H; Ye H; Zou Q; Chen Q; Wei L; Zhang J
    Anal Bioanal Chem; 2020 Jul; 412(19):4549-4554. PubMed ID: 32533226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a time-resolved fluorescence immunoassay for herpes simplex virus type 1 and type 2 IgG antibodies.
    Liang QN; Zhou JW; Liu TC; Lin GF; Dong ZN; Chen ZH; Chen JJ; Wu YS
    Luminescence; 2015 Aug; 30(5):649-54. PubMed ID: 25377426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiphospholipase A2 Receptor Antibody Levels Predict the Risk of Posttransplantation Recurrence of Membranous Nephropathy.
    Quintana LF; Blasco M; Seras M; Pérez NS; López-Hoyos M; Villarroel P; Rodrigo E; Viñas O; Ercilla G; Diekmann F; Gómez-Roman JJ; Fernandez-Fresnedo G; Oppenheimer F; Arias M; Campistol JM
    Transplantation; 2015 Aug; 99(8):1709-14. PubMed ID: 25675198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnostic value of renal phospholipase A2 receptor and serum anti-phospholipase A2 receptor antibody in membranous nephropathy].
    Wu X; Wen S; Zhu X; Yuan S; Xu X; Yang D; Sun L; Liu H; Liu F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Apr; 42(4):395-399. PubMed ID: 28490696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-transplant phospholipase A2 receptor autoantibody concentration is associated with clinically significant recurrence of membranous nephropathy post-kidney transplantation.
    Gupta G; Fattah H; Ayalon R; Kidd J; Gehr T; Quintana LF; Kimball P; Sadruddin S; Massey HD; Kumar D; King AL; Beck LH
    Clin Transplant; 2016 Apr; 30(4):461-9. PubMed ID: 26854647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progress on the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
    Wang C; Lu H; Yang C; Luo Y
    Chin Med J (Engl); 2014; 127(10):1960-3. PubMed ID: 24824263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum with phospholipase A2 receptor autoantibodies interferes with podocyte adhesion to collagen.
    Škoberne A; Behnert A; Teng B; Fritzler MJ; Schiffer L; Pajek J; Lindič J; Haller H; Schiffer M
    Eur J Clin Invest; 2014 Aug; 44(8):753-65. PubMed ID: 24942189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating antibodies to α-enolase and phospholipase A
    Kimura Y; Miura N; Debiec H; Morita H; Yamada H; Banno S; Ronco P; Imai H
    Clin Exp Nephrol; 2017 Feb; 21(1):117-126. PubMed ID: 26830547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.